COVID-19 highlights the acute need for non-invasive, point-of-care, remote monitoring

hemodynamic measurement solutions. Find out how CPS meets the need.

Sensydia in the news

Jan 16, 2024

Sensydia COMPLETES 5TH STUDY FOR HEART-SOUND AI

Non-invasive cardiac assessment company Sensydia announced today that it has completed its 50-subject development study at the University of Minnesota (UMN). This study was conducted at UMN to collect data for its innovative AI-powered, non-invasive Cardiac Performance System (CPS) that uses heart sound analysis to enable earlier detection and more effective therapy guidance for patients suffering from heart failure and pulmonary hypertension.

Learn More

Sensydia Completes Fifth Study for Heart-Sound AI

Sensydia secures $3M NIH grant to advance AI-based cardiac assessment platform

Sensydia raises $8M round to advance breakthrough CPS cardiac assessment platform

Sensydia Achieves Study Target for Heart-Sound AI

Sensydia Receives FDA Breakthrough Device Designation for CPS Non-Invasive Cardiac Monitoring Device

Sensydia Appoints Anthony Arnold as President and Chief Executive Officer